PYC THERAPEUTICS LIMITED — Director's Dealing 2013

Nov 13, 2013

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity PHYLOGICA LIMITED ABN 48 098 391 961

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

We (the entity) give ASX the followingthe director for the purposes of section	information under listing rule 3.19A.2 and as agent for205G of the Corporations Act.
Name of Director	RICHARD MILES HOPKINS
Date of last notice	5th SEPTEMBER 2013

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	INDIRECT
Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving riseto the relevant interest.	RICHARD MILES HOPKINS & MAYA ANNE MAUREENVANDEN DRIESEN <VANHOP SUPERANNUATIONFUND >Trustee & Beneficiary of fund
**Date of change **	12THNOVEMBER 2013
No. of securities held prior to change	DIRECT:- 2,795,564 ORDINARY SHARES- 1,980,000 ORDINARY SHARES RESTRICTED 03/06/14- 1,980,000 ORDINARY SHARES RESTRICTED 03/06/15- 2,040,000 ORDINARY SHARES RESTRICTED 03/06/16- 211,864 PYCOA OPTIONS EXERCISABLE AT $0.09EXPIRING 30/06/16- 1,500,000 INCENTIVE OPTIONS AT $NIL EXPIRING02/12/13INDIRECT:MAYA VANDEN DRIESEN- 164,954 ORDINARY SHARESVANHOP PTY LTD - 1,062,943 ORDINARY SHARESRICHARD MILES HOPKINS & MAYA ANNE MAUREENVANDEN DRIESEN <VANHOP SUPERANNUATIONFUND >- 50 CONVERTING NOTES CONVERTING 02/12/13
Class	1. ORDINARY FULLY PAID2. PYCOA LISTED OPTIONS

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Number acquired	1. 438,596 PYC2. 292,398 PYCOA
Nature of changeExample: on‐market trade, off‐market trade, exerciseof options, issue of securities under dividendreinvestmentplan, participation in buy‐back	CONVERSION OF 50 CONVERTING NOTES
Number disposed	50 CONVERTING NOTES
Value/ConsiderationNote: If consideration is non‐cash, provide details andestimated valuation	1. $0.0114 PER SHARE2. TWO PYCOA FOR EVERY THREE NEW SHARESISSUED
No. of securities held after change	DIRECT:- 2,795,564 ORDINARY SHARES- 1,980,000 ORDINARY SHARES RESTRICTED 03/06/14- 1,980,000 ORDINARY SHARES RESTRICTED 03/06/15- 2,040,000 ORDINARY SHARES RESTRICTED 03/06/16- 211,864 PYCOA OPTIONS EXERCISABLE AT $0.09EXPIRING 30/06/16- 1,500,000 INCENTIVE OPTIONS AT $NIL EXPIRING02/12/13INDIRECT:MAYA VANDEN DRIESEN- 164,954 ORDINARY SHARESVANHOP PTY LTD - 1,062,943 ORDINARY SHARESRICHARD MILES HOPKINS & MAYA ANNE MAUREENVANDEN DRIESEN <VANHOP SUPERANNUATIONFUND >- 438,596 ORDINARY SHARES- 292,398 PYCOA OPTIONS EXERCISABLE AT $0.09EXPIRING 30/06/16
	RICHARD MILES HOPKINS & MAYA ANNE MAURVANDEN DRIESEN <VANHOP SUPERANNUATIOFUND >- 438,596 ORDINARY SHARES- 292,398 PYCOA OPTIONS EXERCISABLE AT $ EXPIRING 30/06/16

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract Nature of interest Name of registered holder (if issued securities) Date of change No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed Interest acquired Interest disposed Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation Interest after change

Part 3 –[+] Closed period

Were the interests in the securities or contracts detailed above traded during a NO + closed period where prior written clearance was required?

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

If so, was prior written clearance provided to allow the trade to proceed during thisperiod?	N/A
Ifprior written clearance wasprovided, on what date was thisprovided?	N/A

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3